Sign In
Buy RIVN
$18.27
+0.98 (+5.67%)
At Close: Jun 03, 2026
Rivian Stock Under $20 -- Is Now the Time to Buy?
12:19am, Tuesday, 17'th Feb 2026
Rivian anticipates vehicle deliveries increasing in 2026 to 62,000 to 67,000. The company posted a gross profit of $144 million in 2025, largely due to its joint venture with Volkswagen.
Riversgold finalises Hawkstone drilling program at Tambourah ahead of early March start
05:19am, Monday, 16'th Feb 2026
Riversgold Ltd (ASX:RGL, FRA:RGV, OTC:RVSGF) has finalised planning for an exploration drilling program at the Hawkstone Prospect within its 100%-owned...
Elixir drills Lorelle-3 to 3,580m, intersects multiple Permian targets
05:15am, Monday, 16'th Feb 2026
Elixir Energy Ltd (ASX:EXR, OTC:ELXPF)' s Lorelle-3 pilot well in Queensland’s Taroom Trough has intersected multiple Permian hydrocarbon reservoir targets,...
Small Cap Watch: Small Ordinaries slides as St George, Aurum, Elixir and peers advance resource projects
04:46am, Monday, 16'th Feb 2026
The S&P/ASX Small Ordinaries (ASX: XSO) fell 2.84% on Friday to 3,612.10, extending its 5-day decline to 1.03% as broader weakness weighed on small-cap...
Better EV Stock: Rivian vs. Nio
02:38am, Monday, 16'th Feb 2026
The global EV market surged in 2025 while the American one contracted. China's market is seeing a few dominant players like BYD and Geely emerge, closing the window for smaller companies like Nio to c
The Week in EV Stocks: Rivian Gains 19.8% While Tesla Lags Behind | RIVN, TSLA
02:06pm, Sunday, 15'th Feb 2026
Rivian Automotive Inc ( NASDAQ:RIVN | RIVN Price Prediction) gained 19.8% this week, closing at $17.73 on Friday, February 13, 2026.
Where Will Rivian Be in 3 Years?
06:05pm, Saturday, 14'th Feb 2026
Rivian will soon compete directly with Tesla. Artificial intelligence (AI) will be a key growth driver.
Wall Street analysts update Rivian's stock price
11:47am, Saturday, 14'th Feb 2026
Wall Street analysts are reassessing their outlook on Rivian Automotive (NASDAQ: RIVN) as the electric vehicle maker navigates a volatile start to the year.
Weekend Morning Brew: AI Jitters, Novo--Hims Clash, McDonald's Beat
07:37am, Saturday, 14'th Feb 2026
Weekly Market HighlightsWeekly breadth was slightly negative with 4,703 advancers versus 4,832 decliners, even as 963 stocks gained more than 10% and 1,151 fel
Aftermath Silver kicks off PFS at Berenguela project - ICYMI
07:05am, Saturday, 14'th Feb 2026
Aftermath Silver Ltd (TSX-V:AAG, OTCQX:AAGFF, FRA:FLM1) earlier this week announced the formal launch of a pre-feasibility study (PFS) for its Berenguela...
Medicus Pharma’s Teverelix Phase 2b trial cleared by FDA - ICYMI
06:19am, Saturday, 14'th Feb 2026
Medicus Pharma (NASDAQ:MDCX) CEO Raza Bokhari talked with Proactive about the FDA's clearance to begin a Phase 2b dose optimization study for Teverelix, the...
Standard Uranium starts Corvo drilling program - ICYMI
05:02am, Saturday, 14'th Feb 2026
Standard Uranium Ltd (TSX-V:STND, OTCQB:STTDF, FRA:9SU0) earlier this week announced the start of drilling at its Corvo project, marking the first of...
Nextech3D.ai adds corporate gifting to platform - ICYMI
04:10am, Saturday, 14'th Feb 2026
Nextech3D.AI (CSE:NTAR, OTCQX:NEXCF, FRA:1SS) earlier this week announced the launch of a corporate gifting offering through its Kraftylab platform, marking...
Virtuix expands Omni VR treadmill to Europe – ICYMI
03:58am, Saturday, 14'th Feb 2026
Virtuix Holdings Inc (NASDAQ:VTIX) CEO Jan Goetgeluk talked with Proactive about the company’s official expansion into the European consumer market with its...
Immunic MS trial shows reduced brain lesions - ICYMI
03:03am, Saturday, 14'th Feb 2026
Immunic Inc (NASDAQ:IMUX)’s chief medical officer Dr Andreas Muehler talked with Proactive about new data presented at the ACTRIMS Forum in San Diego,...
